Exelixis (EXEL) FCF Margin (2010 - 2026)
Exelixis (EXEL) recorded quarterly FCF Margin of 40.98% in Q2 2026, down 26.18% quarter-over-quarter from 55.52% in Q1 2026, and up 345.0% on a YoY basis from 9.21% in Q2 2025.
Exelixis (EXEL) FCF Margin (2010 - 2026) Analysis & Trends
Exelixis' FCF Margin history runs 17 years deep, the most recent figure standing at 40.98% for Q2 2026.
- In Q2 2026, FCF Margin rose 345.0% year-over-year to 40.98%; the TTM figure through Apr 2026 stood at 38.63% (up 292.0% YoY), while the FY2026 annual figure was 37.75%, up 678.0% from the prior year.
- FCF Margin was 40.98% for Q2 2026 at Exelixis, down from 55.52% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 55.52% in Q1 2026 to a low of 0.53% in Q4 2023.
- Historically, FCF Margin has averaged 27.25% across 5 years, with a median of 24.48% in 2023.
- The sharpest annual moves came in 2022 and 2025: FCF Margin slumped 4364 bps in 2022, then surged 4223 bps in 2025.
- A 5-year view of FCF Margin shows it stood at 15.09% in 2022, then slumped by 104 bps to 0.53% in 2023, then surged by 9224 bps to 48.77% in 2024, then retreated by 1 bps to 48.32% in 2025, then dropped by 15 bps to 40.98% in 2026.
- The last three FCF Margin figures came in at 40.98% (Q2 2026), 55.52% (Q1 2026), and 48.32% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -3.98% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | 40.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 40.98% |
| Jan 2, 2026 | 55.52% |
| Oct 3, 2025 | 48.32% |
| Jul 4, 2025 | 8.12% |
| Apr 4, 2025 | 37.53% |
| Jan 3, 2025 | 41.69% |
| Sep 27, 2024 | 48.77% |
| Jun 28, 2024 | 17.73% |
| Mar 29, 2024 | 13.91% |
| Dec 29, 2023 | -0.53% |
| Sep 29, 2023 | 22.88% |
| Jun 30, 2023 | 24.48% |
| Mar 31, 2023 | 17.71% |
| Dec 30, 2022 | 15.09% |
| Sep 30, 2022 | 25.51% |
| Jul 1, 2022 | 5.67% |
| Apr 1, 2022 | 39.92% |
| Oct 1, 2021 | 12.23% |
| Jul 2, 2021 | 49.31% |
| Apr 2, 2021 | 9.62% |